Indications and uses
As a lubricant to relieve dryness of the eye. As a protectant against further irritation of the eye. For temporary relief of burning, irritation, and discomfort including exposure to wind or sun.
TheraTears Liquid Night PF 58790-003
- Manufacturer
- MEDTECH PRODUCTS INC
- Effective date
- 2026-09-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 12
- Source
- daily-update
- Hydrated at
- 2026-09-11 03:02:30
Label at a glance#
ProductTheraTears
Active ingredientCARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
Label structure10 sections
Dosage and administration
To open, twist tab completely off. Instill 1 or 2 drops in the affected eye(s) as needed.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient (In each unit dose)
sodium carboxymethylcellulose 1%
Purpose
Eye lubricant
Uses
- As a lubricant to relieve dryness of the eye.
- As a protectant against further irritation of the eye.
- For temporary relief of burning, irritation, and discomfort including exposure to wind or sun.
Warnings
For external use only
- To avoid contamination do not touch tip of opened container to any surface. Do not reuse. Once opened discard. Use individual vials within 90 days of opening foil pouch.
- This product contains no preservatives. Any solution not used immediately after opening should be discarded. Re-use of this single-use product may lead to inflammation of the eye and/or discomfort, based on potential contamination during handling.
Do not use
- If solution changes color or becomes cloudy.
Stop use and ask a doctor if
- You experience eye pain, changes in vision, continued redness or irritation.
- Condition worsens or persists for more than 72 hours.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center immediately.
Directions
- To open,
twist tab completely off.
- Instill 1 or 2 drops in the affected eye(s) as needed.
Other information
- Store between 15C-25C (59F-77F)
- Do not touch unit-dose tip to eye.
Inactive ingredients
boric acid, calcium chloride, magnesium chloride, potassium chloride, sodium bicarbonate, sodium borate,sodium chloride, sodium phosphate ,water
Questions or comments? 1-800-579-8327
Principal Display Panel Text for Carton Label:
PRESERVATIVE
FREE
RECOMMENDED
DOCTOR
CREATED
thera
tears®
THERAPY FOR YOUR EYES®
Liquid Gel
nighttime
dry eye therapy
LUBRICANT EYE GEL
SOOTHING
OVERNIGHT
RELIEF
30 STERILE
Single-Use Vials* 0.60 FL OZ (18.0 mL) TOTAL
Principal Display Panel Text for Carton Label:
PRESERVATIVE
FREE
RECOMMENDED
DOCTOR
CREATED
thera
tears®
THERAPY FOR YOUR EYES®
Liquid Gel
nighttime
dry eye therapy
LUBRICANT EYE GEL
SOOTHING
OVERNIGHT
RELIEF
4 Single-Use Vials 0.08 FL OZ (2.4 mL) TOTAL
DailyMed Product Concepts#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58790-002-28 | EA - Each | 58790-002 | 4882d8d7-c2b4-413d-a4ef-50384ddb630b | 1 | 2013-02-13 |
| 58790-003-30 | EA - Each | 58790-003 | 728d47fb-79ea-403c-840b-2ffb93816929 | 1 | 2020-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| carboxymethylcellulose sodium | ACTIVE INGREDIENT | K679OBS311 | 1 | |
| carboxymethylcellulose | ACTIVE MOIETY | 05JZI7B19X | 1 | |
| boric acid | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| calcium chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 1 | |
| magnesium chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| sodium bicarbonate | INACTIVE INGREDIENT | 8MDF5V39QO | 1 | |
| sodium borate | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| sodium phosphate | INACTIVE INGREDIENT | SE337SVY37 | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- TheraTears
- carboxymethylcellulose sodium
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
- CARBOXYMETHYLCELLULOSE
- BORIC ACID
- SODIUM BORATE
- CALCIUM CHLORIDE
- MAGNESIUM CHLORIDE
- POTASSIUM CHLORIDE
- WATER
- SODIUM BICARBONATE
- SODIUM CHLORIDE
- SODIUM PHOSPHATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58790-002 | 58790-002-28 |
| 58790-003 | 58790-003-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 11 | 2025-10-23 | full-release | 2026-06-01 01:39:48 |
| 10 | 2024-12-13 | full-release | 2026-06-01 00:41:49 |
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 160 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | GRANULE, EFFERVESCENT / ORAL | 267 mg | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION / OPHTHALMIC | 0.01 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| boric acid | BORIC ACID | R57ZHV85D4 | GEL / OPHTHALMIC | 0.5 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | SOLUTION / OPHTHALMIC | 2 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING / ORAL | 107 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 4 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | SOLUTION / OPHTHALMIC | 0.81 %w/w | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | SUSPENSION / OPHTHALMIC | 0.2 %w/w | ||
| boric acid | BORIC ACID | R57ZHV85D4 | GEL / OPHTHALMIC | 0.5 %w/w | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INSERT / VAGINAL | 129 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | LOZENGE / ORAL | 100 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 160 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAMUSCULAR | 175 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVITREAL | 0.18 %w/v | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / BUCCAL | 42 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVENOUS | 812 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, EXTENDED RELEASE / ORAL | 81 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, CHEWABLE / ORAL | 140 mg | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | POWDER, FOR SOLUTION / ORAL | 1250 mg/100ml | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAMUSCULAR | 175 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | SOLUTION / RESPIRATORY (INHALATION) | 2 %w/w | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | GUM, CHEWING / BUCCAL | 240 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRATHECAL | 0.05 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, COATED / ORAL | 10.6 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / SUBLINGUAL | 6 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVENOUS | 812 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 3059 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRATHECAL | 0.05 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, EFFERVESCENT / ORAL | 57600 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, CHEWABLE / ORAL | 140 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, SOLUTION / INTRAVENOUS | 52 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | SUSPENSION / OPHTHALMIC | 0.2 %w/w | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / ORAL | 1300 mg | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | SUSPENSION/ DROPS / OPHTHALMIC | 0.03 %w/w | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INSERT / VAGINAL | 129 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | LOZENGE / ORAL | 100 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, EFFERVESCENT / ORAL | 57600 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE / ORAL | 320 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 3059 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | GUM, CHEWING / ORAL | 360 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 6 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | SUSPENSION/ DROPS / OPHTHALMIC | 0.03 %w/w | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING / ORAL | 107 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 4 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | ADJ PH | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION / OPHTHALMIC | 1 mg | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | POWDER, FOR SOLUTION / ORAL | 1250 mg/100ml | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3219 mg | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | EMULSION / OPHTHALMIC | 0.11 %w/v | ||
| sodium bicarbonate | SODIUM BICARBONATE | 8MDF5V39QO | GUM, CHEWING / BUCCAL | 240 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | 58790-002-28 58790-003-30 58790-002 58790-003 58790000330 58790000228 5b0f0fc3-3f46-4acb-e063-6294a90a72af 17a01236-130f-495b-9f8d-92b6a23b2dc5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.